Please assess the completion status of the following clinical trial:

Trial Title: Trial of the PresVIEW Implant for the Improvement of Near Vision in Patients With Presbyopia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subject must be between 50-60 years old~* Subject must have a best corrected distance visual acuity of 20/20 or better~* Subject must have SLOAN distance corrected near visual acuity @ 40cm in the operative eye/eyes of 20/50 to 20/100 (inclusive).~* Subject should have a manifest distance spherical equivalent refractive correction in the operative eye/eyes of from -0.50 to +0.75 diopters with no more than 1.00 diopter of astigmatism and should require at least a +1.50 diopter add. The distance manifest refraction spherical equivalent and the distance cycloplegic refraction spherical equivalent must be within 0.50 diopters of each other.~* Subject must be phakic in the study eye~* Subject must be mentally competent to understand and comply with the requirements of the study.~* Subject must be able to provide written informed consent.~Exclusion Criteria:~* Chronic uveitis or other recurrent anterior or posterior segment inflammation in either eye.~* Scleral thickness less than 530 μm in the operative eye/eyes.~* Any previous eye surgeries including cataract, LASIK, or Muscle surgery~* Any history of prior extraocular muscle surgery, specifically the recti or oblique muscles.~* Any chronic systemic diseases such as diabetes, heart disease, Lupus, etc.~* Any eye diseases such as eye inflammation, infection, cataract, or retinal diseases~* Allergic to any medications used in the study.~* The patient may not have participated in a device clinical study for the operative eye within the last 3 months and may not have been implanted with PSI devices in this or any other study.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Implantation-Non Randomized (Type: EXPERIMENTAL): Subjects are not participants in the randomized sub-study. PresView Scleral Implants surgical placed in the eye(s) after enrollment and meeting inclusion/exclusion criteria.
- Implantation-Randomized (Type: EXPERIMENTAL): Subjects are participants in the randomized sub-study. Subjects were randomized to the Immediate Treatment group. PresView Scleral Implants surgical placed in the eye(s)Subjects are participants in the randomized sub-study after enrollment and meeting inclusion/exclusion criteria.
- Deferred Implantation-Randomized (Type: NO_INTERVENTION): Subjects are participants in the randomized sub-study after enrollment and meeting inclusion/exclusion criteria. Subjects were randomized to the Deferred Treatment group are observed for 6 months. Upon completion of the observation follow-up, subjects can opt to have PresView Scleral Implants surgically placed in the eye(s) and become part of the overall study experimental group.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete